Charles River Laboratories Stock Surges 15% in Morning Trading Amid Strong Earnings and Revenue Growth

Thursday, Jul 24, 2025 5:53 am ET1min read

Charles River Laboratories (CRL) stock price rose by $15.11 to $164.90 in morning trading, marking a notable gain in the liquid option market. Analysts forecast an average target price of $158.53, with a high estimate of $200 and a low estimate of $70. The average target implies a 4.49% downside from the current price. The estimated GF Value for CRL in one year is $203.26, suggesting a 22.45% upside.

Charles River Laboratories (CRL) stock price experienced a significant increase in morning trading, rising by $15.11 to reach $164.90. This upward movement positions CRL among the top performers in the liquid option market [1].

Analysts have forecasted an average target price of $158.53 for CRL, with a high estimate of $200 and a low estimate of $70. The average target implies a 4.49% downside from the current price of $165.99. The estimated GF Value for CRL in one year is $203.26, suggesting a 22.45% upside [1].

The company reported mixed results for the first quarter of 2025. Revenue decreased by 2.7% year-over-year, with an organic decline of 1.8% across all business segments. However, the company's operating margin increased by 60 basis points year-over-year, driven by cost savings from restructuring initiatives. Earnings per share (EPS) rose by 3.1% from the first quarter of 2024, supported by improvements in operating margin and reductions in tax rate and interest expense [1].

CRL's stock price surge can be attributed to investor interest and confidence in the company's potential growth and performance. The company is actively investing in New Approach Methods (NAMs) and has a growing portfolio of capabilities in preclinical drug development, positioning itself as a leader in the field [1].

References:
[1] https://www.gurufocus.com/news/2994183/charles-river-crl-stock-rises-over-15-in-morning-trading-crl-stock-news
[2] https://www.inkl.com/news/d-r-horton-iqvia-holdings-northrop-grumman-and-other-big-stocks-moving-higher-on-tuesday
[3] https://finance.yahoo.com/news/look-fair-value-charles-river-143909176.html

Charles River Laboratories Stock Surges 15% in Morning Trading Amid Strong Earnings and Revenue Growth

Comments



Add a public comment...
No comments

No comments yet